Splenic irradiation following chemotherapy in chronic myelogenous leukemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001792:Blood Platelets; D001855:Bone Marrow Diseases / Q000209:etiology / Q000473:pathology; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D003036:Cobalt Isotopes / Q000627:therapeutic use; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000532:radiotherapy*; D007958:Leukocyte Count; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D011878:Radiotherapy / Q000009:adverse effects*; D012075:Remission, Spontaneous; D013154:Spleen / Q000528:radiation effects*; D013997:Time Factors
D003036:Cobalt Isotopes; D006454:Hemoglobins; D015122:Mercaptopurine; D002066:Busulfan; D006918:Hydroxyurea